This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Health Care Winners & Losers: Intuitive Surgical

Stocks in this article: VAR HOLX ISRG

Updated from 4:13 p.m. ET

Shares of medical-equipment makers Varian Medical Systems (VAR - Get Report) and Hologic ( HOLX) fell Thursday after their competitor, Intuitive Surgical (ISRG - Get Report) announced weaker-than-expected fourth-quarter sales as hospitals cut spending on new equipment.

Late Wednesday, Sunnyvale, Calif.-based Intuitive said fourth-quarter sales rose 22%, but the figure still fell short of Wall Street expectations. The company cited a weak economy as the culprit in lower-than-expected surgical device sales.

Intuitive closed down $7.34 or 6.2% to $110.54 after the shares fell to a low of $99.75 during the session, their lowest point in nearly two years.

"This reaffirms our view that hospital capital equipment spending materially deteriorated in the fourth and that 2009 capital expenditure budgets will continue to face pressure," said Citi analyst Amit Bhalla, in a note to investors.

Palo Alto, Calif.-based Varian and Bedford, Mass.-based Hologic both make different products, but also count hospitals as key customers. With the economy lagging, hospitals and other health care providers have been cutting costs and spending, which includes buying less new equipment.

Shares of Hologic, which makes diagnostic and imaging systems geared toward women's health, fell 71 cents, or 5.9%, to $11.43 for the day. The stock has traded between $10.54 and $35.79 over the last 52 weeks.

Meanwhile, shares of Varian, which makes radiation therapy systems, fell $1.62, or 4.7%, to $32.42 in midday trading. The stock reached a low of $30.04 earlier in the session, its lowest point in more than five years.

Bhalla said the lagging economy is likely to hurt sales of Hologic's digital mammography systems, but reaffirmed a "Buy" rating. He reaffirmed a "Hold" rating on Varian, citing likely weakness in new orders.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs